MINOSTA TABLET
₹115.2*
MRP ₹128
10% off
₹109*
MRP ₹128
15% CB
₹19 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
MINOSTA TABLET belongs to the class of dietary supplements primarily used to treat low blood calcium levels. It effectively treats various conditions caused by low calcium levels in the body, such as osteoporosis (weak and brittle bones), osteomalacia/rickets (weak bones), hypoparathyroidism (low levels of parathyroid hormone), and latent tetany (a muscle disease with low blood calcium levels). MINOSTA TABLET can also be given to pregnant, nursing, and postmenopausal women to ensure that they are getting enough calcium.
MINOSTA TABLET consists of three medicines: Calcium (mineral), Calcitriol (Vitamin D3), and Menaquinone (Vitamin K2). Calcium is a mineral that is used to prevent or treat a calcium deficiency. It provides essential nutrients to maintain bone formation and maintenance. Calcitriol is a synthetic version of Vitamin D3 and treats calcium deficiency with hypoparathyroidism (the parathyroid glands' decreased activity) and metabolic bone diseases in people with chronic kidney failure. It raises Vitamin D levels and thereby increases calcium levels in the blood. This helps in improving the absorption rate of calcium from the intestine. Menaquinone is also known as Vitamin K2. Vitamin K2 helps to maintain bone density by promoting calcium transport from the bloodstream into the bone. Calcium-regulating proteins also require menaquinone in the arteries.
Your doctor will decide the dosage based on your medical condition. In some cases, MINOSTA TABLET can cause side effects like constipation or stomach upset, nausea, vomiting, loss of appetite, mood changes, weakness, tiredness, fast or pounding heartbeat, bone/muscle pain, and headache. Most of these side effects of MINOSTA TABLET do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.
If you are known to be allergic to MINOSTA TABLET or its inactive components, please inform your doctor. Please tell your doctor if you have hypercalcemia (high calcium levels), hypervitaminosis D (high vitamin D levels), and malabsorption syndrome (difficulty absorbing nutrition from food). Brief your medical history if you have any heart/kidney/liver/blood vessel diseases, and kidney stones before starting MINOSTA TABLET. Pregnant or breastfeeding women should consult their doctor before taking MINOSTA TABLET. Higher doses of Vitamin D than the recommended daily dose should be used in pregnant women only when advised by the doctor. MINOSTA TABLET may pass into the breast milk; hence, breastfeeding mothers need to seek medical advice before starting MINOSTA TABLET.
MINOSTA TABLET is used to treat low blood calcium levels and various associated conditions caused by low calcium levels in the body, such as osteoporosis (weak and brittle bones), osteomalacia/rickets (weak bones), hypoparathyroidism (low levels of parathyroid hormone), and tetany (a muscle disease with low blood calcium levels). MINOSTA TABLET consists of Calcium (mineral), Calcitriol (Vitamin D3), and Menaquinone (Vitamin K2). Calcium is a mineral and prevents or treats calcium deficiency. It helps to maintain bone and teeth health. Calcitriol, a synthetic form of Vitamin D3, treats calcium deficiency with hypoparathyroidism (the parathyroid glands' decreased activity) and metabolic bone diseases in people with chronic kidney failure. Menaquinone, also known as Vitamin K2, helps maintain bone density by promoting calcium transport from the bloodstream into the bone. Calcium-regulating proteins are also required in the arteries.
Let your doctor know if you are allergic to MINOSTA TABLET or its inactive components. Brief your medical history if you have any heart/kidney/liver/blood vessel diseases, kidney stones, sarcoidosis (growth of inflammatory cells in different parts of the body), Crohn's disease (inflammatory bowel disease), Whipple's disease (bacterial infection affecting joints and digestive system), achlorhydria (little or no stomach acid), low levels of bile, and phosphate imbalance. Chewable tablets of MINOSTA TABLET contain sugar or aspartame; hence, caution should be taken when having diabetes and phenylketonuria (increased levels of an amino acid called phenylalanine). Calcitriol in higher doses may harm the foetus. Higher doses of Vitamin D than the recommended daily dose should be used in pregnant women only when advised by the doctor. MINOSTA TABLET may pass into the breast milk; hence, consult your doctor before taking MINOSTA TABLET if you are a breastfeeding mother.
Drug-Drug Interaction: MINOSTA TABLET may interact with central nervous system stimulants (dextroamphetamine), anti-depressants (duloxetine), minerals (ferrous sulfate), anti-ulcer drugs (ranitidine), synthetic thyroid hormone (levothyroxine), painkillers (aspirin), calcium supplements (ergocalciferol), anti-clotting drugs (warfarin), drugs treating high cholesterol levels (cholestyramine), and drugs that treat high blood phosphorus levels (sevelamer). Some medications like tetracycline antibiotics (doxycycline), quinolone antibiotics (ciprofloxacin), drugs treating bone loss (alendronate), weight-loss drugs (orlistat), and anti-cancer drugs (estramustine) may affect the calcium absorption into the body.
Drug-Food Interaction: Avoid or reduce the intake of caffeine, soft drinks and alcohol that inhibit calcium absorption.
Drug-Disease Interaction: MINOSTA TABLET is not recommended if you have hypercalcemia (high calcium levels), hypervitaminosis D (high vitamin D levels), and malabsorption syndrome (difficulty absorbing nutrition from food).
Osteoporosis: It is a bone disease that makes the bones weak and brittle by decreasing bone density. It is known as a silent disease since it is not revealed until a bone is broken easily or fractured. Symptoms include backache, easily breaking bones, and hunched or stooped posture. Thinning of bones can be prevented by treatment with medications, calcium supplements, a calcium-rich diet, and lifestyle changes.
Osteomalacia/Rickets: A bone disease caused by softening and weakening bones in children due to inadequate vitamin D.
Tetany: A disease condition due to low levels of calcium (hypocalcaemia) in the body that causes cramps and spasms in the hands, feet, and larynx (voice box.
Hypoparathyroidism: It is a disease characterized by low levels of parathyroid hormone. This can cause low calcium levels and trigger tetany.
Alcohol
Caution
Drinking alcohol can affect calcium absorption; hence it is advised to limit the alcohol intake while using MINOSTA TABLET.
Pregnancy
Caution
During pregnancy, use higher doses of MINOSTA TABLET than the daily dietary allowance only when advised by the doctor. Your doctor will weigh the potential risks and benefits before recommending MINOSTA TABLET.
Breast Feeding
Caution
Consult your doctor before taking MINOSTA TABLET if you are breastfeeding. MINOSTA TABLET can pass into the breast milk. If MINOSTA TABLET is used during breastfeeding, please monitor the mother and the infant's serum calcium levels.
Driving
Safe
No interaction found/established.
Liver
Caution
Let your doctor know if you have any history of liver diseases before taking MINOSTA TABLET. Hepatic impairment/liver disease can alter the metabolic and therapeutic activity of certain Vitamin D forms.
Kidney
Caution
It is advised to seek doctor advice before starting MINOSTA TABLET if you have kidney diseases like kidney stones or undergoing dialysis.
Children
Consult your doctor
The doctor will decide the dosage of MINOSTA TABLET based on the child's age and weight.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes